Oculis Holding AG (OCS) Depreciation & Amortization (CF) (2022 - 2024)

Oculis Holding AG (OCS) recorded quarterly Depreciation & Amortization (CF) of $33224.8 in Q1 2024, down 84.57% quarter-over-quarter from $215324.7 in Q4 2023, and down 12.2% on a YoY basis from $37840.7 in Q2 2023.

Oculis Holding AG (OCS) Depreciation & Amortization (CF) (2022 - 2024) Analysis & Trends

Oculis Holding AG's Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $33224.8 for Q1 2024.

  • In Q1 2024, Depreciation & Amortization (CF) fell 12.2% year-over-year to $33224.8; the TTM figure through Dec 2024 stood at $33224.8 (down 89.67% YoY), while the FY2025 annual figure was $683138.7, up 47.4% from the prior year.
  • Depreciation & Amortization (CF) was $33224.8 for Q1 2024 at Oculis Holding AG, down from $215324.7 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $215324.7 in Q4 2023 to a low of $32832.4 in Q3 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $85078.7 across 3 years, with a median of $35589.6 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) advanced 3.72% in 2023, then declined 12.2% in 2024.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $207604.4 in 2022, then gained by 3.72% to $215324.7 in 2023, then sank by 84.57% to $33224.8 in 2024.
  • The last three Depreciation & Amortization (CF) figures came in at $33224.8 (Q1 2024), $215324.7 (Q4 2023), and $32832.4 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 1,395.22
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 55.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 429,663.65
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 33,224.79
Mar 31, 2024 33,224.79
Dec 31, 2023 215,324.70
Dec 31, 2023 215,324.70
Sep 30, 2023 32,832.42
Sep 30, 2023 32,832.42
Jun 30, 2023 35,589.62
Jun 30, 2023 35,589.62
Mar 31, 2023 37,840.69
Mar 31, 2023 37,840.69
Dec 31, 2022 207,604.38
Dec 31, 2022 207,604.38
Sep 30, 2022 33,134.61
Sep 30, 2022 33,134.61